COMESSATTI, Alessandra
COMESSATTI, Alessandra
Dip. SCIENZE BIOMEDICHE ED ONCOLOGIA UMANA (attivo dal 01/01/1900 al 30/04/2013)
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients.
2006-01-01 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Fierro MT.
Le infezioni nella micosi fungoide e nella sindrome di Sézary
2011-01-01 Fierro MT; Cuffini AM; Novelli M; Banche G; Allizond V; Comessatti A; Scalas D; Merlino C; Bernengo MG
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients.
2008-01-01 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Lisa F; Fierro MT
Phenotypic features and TCR gene rearrangements patterns in Sezary sindrome: diagnostic, prognostic and response associated parameters
2011-01-01 Quaglino P; Novelli M; Comessatti A; Ponti R; Fierro MT; Bernengo MG
Phenotypical and functional alterations of polymorphonucleates in sezary syndrome patients
2009-01-01 M. Novelli; P. Quaglino; C. Merlino; G. Banche; M.T. Fierro; A. Comessatti; R. Ponti; A Cuffini; M.G. Bernengo
Treatment of Sézary Syndrome by anti-CD52 monoclonal antibodt Alemtuzumab: clinical and immunological findings in 24 patients
2010-01-01 Bernengo MG; Quaglino P; Marenco F; Novelli M; Comessatti A; Savoia P; Fierro MT